Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04827446 · ClinicalTrials.gov registry record · NA

Lighting Intervention for Cancer-related Fatigue

A NA study, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
139
Enrollment target

NCT04827446 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 139 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04827446, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target

Study Summary

Fatigue is a major problem for cancer patients, and one that can persist long after treatment ends. Recent work has demonstrated that light therapy may mitigate or reduce fatigue levels in both cancer patients and cancer survivors. This protocol seeks to assess how lighting interventions distributed through a mobile app affect fatigue, sleep, and quality of life across three populations of cancer patients: breast cancer and prostate cancer, and patients who have undergone autologous hematopoietic stem cell transplant (HSCT). Participants will be randomized 1:1 to either the interventional SYNC app or to a control app.

Interventions

  • OTHER Wearable Sensor
  • OTHER Blue-blocking glasses
  • OTHER Clear glasses
  • OTHER Full SYNC app
  • OTHER "Dummy" SYNC app

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2021-07-15
Est. Completion 2023-03-09
Phase NA

What the Registry Record Tells You About NCT04827446

The ClinicalTrials.gov registry entry for NCT04827446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Wearable Sensor is the first listed.

NCT04827446 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04827446 about?

NCT04827446 is a clinical study titled "Lighting Intervention for Cancer-related Fatigue". Fatigue is a major problem for cancer patients, and one that can persist long after treatment ends. Recent work has demonstrated that light therapy may mitigate or reduce fatigue levels in both cancer patients and cancer survivors. This protocol seeks to assess how lighting interventions distributed...

What is the current status of trial NCT04827446?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2021-07-15. Estimated completion is 2023-03-09.

What interventions are being tested in trial NCT04827446?

The interventions under investigation include: Wearable Sensor (OTHER), Blue-blocking glasses (OTHER), Clear glasses (OTHER), Full SYNC app (OTHER), "Dummy" SYNC app (OTHER).

Who is sponsoring clinical trial NCT04827446?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.